Company profile for Horizon Discovery Group

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Horizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease, and the development of molecular cell and gene therapies to enable precision medicine. The company’s products and services are used by thousands of scientists working in academic institutes, pharmaceutical companies a...
Horizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease, and the development of molecular cell and gene therapies to enable precision medicine. The company’s products and services are used by thousands of scientists working in academic institutes, pharmaceutical companies and clinical diagnostic laboratories around the globe. Horizon is headquartered in Cambridge, UK.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
8100 Cambridge Research Park Waterbeach Cambridge, Cambridgeshire CB25 9TL, ...
Telephone
Telephone
1800 678 242
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/horizon-tool-inc-706567-06062025

FDA
17 Jun 2025

https://endpts.com/perkinelmer-hits-the-checkbook-again-this-time-doling-out-260m-for-next-gen-therapy-bioservices-firm/

Kyle Blankenship ENDPTS
13 May 2021

http://www.pharmtech.com/horizon-discovery-licenses-knockout-cho-cell-line-ngm-biopharmaceuticals

PHARMATECH
06 Feb 2020

https://www.businesswire.com/news/home/20200113005611/en

BUSINESSWIRE
13 Jan 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty